Recruiting ‘Fighting Cells’ to Destroy Tumors

Written on |

TAU discovery of cell interaction may serve as basis for improved cancer treatments.

Tel Aviv University researchers have found that our body’s natural defenses can help destroy malignant tumors. The team found that white blood cells called ‘eosinophils’ fight cancer in two ways: they can destroy the cancer cells themselves, and also recruit the immune system’s cancer-fighting T-cells – another type of white blood cells key to protecting the body against infection. These findings may contribute to the development of new immunotherapies.

Fighting Cancer from Within

The discovery comes as the rising number of cancer cases every year has contributed to a boom in immunotherapy, a treatment that activates the body’s immune system to fight disease. Compared to traditional techniques like chemotherapy, immunotherapy generally leads to longer protection from cancer and fewer side effects.

“Enhancing the number and power of T-cells is one of the main targets of immunotherapy treatments administered to cancer patients today,” said lead researcher, Prof. Ariel Munitz of TAU’s Department of Microbiology and Clinical Immunology at the Sackler Faculty of Medicine. “We discovered a new interaction that summons large quantities of T-cells to cancer tissues, and our findings may have therapeutic implications. Ultimately, our study may serve as a basis for the development of improved immunotherapeutic medications that employ eosinophils to fight cancer.”

Repurposing Cells’ “Destructive” Qualities

Eosinophils produce powerful destructive proteins originally intended for fighting parasites. However, in the modern Western world, where high levels of hygiene have significantly reduced the risk of many parasites, eosinophils often have a negative impact on humans, inducing phenomena like allergies and asthma.

Considering the destructive power of eosinophils, the researchers decided to test the potential benefits of these white blood cells if turned against cancer cells.

For two main reasons, they decided to focus their study on lung metastases, or cancer that started in another part of the body and spread to the lungs: “First, metastases, and not the primary tumors, are often the main problem in treating cancer. The lungs are a major target for the metastasis of many types of cancer,” said Prof. Munitz. “Second, in a preliminary study we demonstrated that eosinophils gather in tumors developing in mucous tissues like the lungs, and therefore assumed that they would be found in lung metastases as well.”

Summoning Reinforcement

The researchers examined tissue samples taken from breast cancer patients. They found that the eosinophils reach the lungs and penetrate the cancer tissues, where they often release their destructive proteins and summon T-cells for reinforcement. Ultimately, T-cells gather in the affected lungs, slowing the growth of tumors.

Additionally, the researchers found that in the absence of eosinophils, the lung tumors were much larger than those exposed to the white blood cells. These findings led to the conclusion that eosinophils fight cancer effectively.

Along with Prof. Munitz, the study was led by TAU PhD student Sharon Grisaru. The findings were published in the journal Cancer Research, published by the American Association for Cancer Research. The initiative was funded by ICRF (Israel Cancer Research Fund), the Israel Cancer Association, ISF (the Israel Science Foundation) BSF (U.S.-Israel Binational Science Foundation) and GSK.  

Featured image: Illustration: Eosinophil, a white blood cell in 3D

Related posts

Medicinal Cannabis Oil Effective for Treating Autism

22 December 2021

TAU Students Racing Towards a Greener Campus

21 December 2021

Parent Smartphone Use Could Harm Child Development

20 December 2021

Breakthrough TAU Discovery Key to Reversing ALS

17 December 2021

Experimental Drug Displays Effectiveness in Treating Symptoms of Autism and Alzheimer’s Disease

16 December 2021

New Ethical Code for World Research of Ancient DNA

15 December 2021

Saving Lives with Artificial Intelligence

9 December 2021

TAU Experts on Omicron: “Don’t Panic”

7 December 2021

Britain and Israel Team Up on Challenge of Healthy Ageing

11 November 2021

TAU Researchers Identify COVID Proteins that Cause Strokes and Heart Attacks

8 November 2021

Help A Friend Out?

7 October 2021

Can’t Multitask Anymore?

6 October 2021

Why Do We Squabble Over The AC?

5 October 2021

The Immune System’s Double Agents

5 October 2021

TAU Team Reverses Early Signs of Alzheimer’s

10 September 2021

Nicotine Testing of Children Curbs Parents’ Smoking

6 September 2021

Victoria

Tok Corporate Centre, Level 1,
459 Toorak Road, Toorak VIC 3142
Phone: +61 3 9296 2065
Email: office@aftau.asn.au

New South Wales

P.O. Box 4044, Maroubra South,
NSW 2035
Phone: +61 418 465 556
Email: davidsolomon@aftau.org.au

Western Australia

P O Box 36, Claremont,
WA  6010
Phone: :+61 411 223 550
Email: clivedonner@thelinqgroup.com